Proteomics Market to Grow at 18.2% During 2022-2027, Spurred by Rising Preference for Personalized Medicines

According to the latest report by IMARC Group, titled "Proteomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022- 2027," the global proteomics market reached a value of US$ 26.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 66.5 Billion by 2027, exhibiting a CAGR of 18.2% during 2022-2027.

Proteomics refers to the study of protein structure and physiological function. It includes understanding the modifications and alterations that generally take place in existing proteins when they are subjected to varying conditions. It also studies and analyses which proteins are expressed and their structures in both active and inactive states to further understand their roles and how they interact with other proteins. This is done by the widespread integration of numerous advanced technologies with proteomics for quantifying and identifying proteins and diagnostic markers. Apart from this, it also deals with the evaluation of the rate of protein production as well as the interaction patterns of proteins. As a result, it finds extensive applications in drug discovery and the development of personalized medicines.

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviors of the consumers globally-our estimates about the latest market trends and forecast values after considering the impact of this pandemic. These observations will be integrated into the report.

Request for a free sample copy of this report: https://www.imarcgroup.com/proteomics-market/requestsample

Global Proteomics Market Trends:

The global market is majorly driven by the increasing demand for personalized medicines. Along with this, continual developments in drug discovery and biotechnology is providing an impetus to market growth. The deployment of proteomic systems assists in simplifying the process of drug discovery and forms an essential part of the chemical synthesis and biological testing of numerous drugs. The market is further driven by the technological advancements and extensive research and development (R&D) activities conducted by the players. This has led to the development of a quantitative and qualitative analysis of proteins that consequently assists in the identification of cancer therapies and treatments, thereby acting as a major growth-induing factor. Some of the other factors contributing to the proteomics market growth include continual developments in the existing healthcare infrastructure and numerous favorable government policies that promote research and drug discovery activities across the globe.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/proteomics-market

Competitive Landscape with Key Players:

• Agilent Technologies Inc.
• Bio-RAD Laboratories Inc.
• Bruker Corporation
• Creative Proteomics
• Danaher Corporation
• GE Healthcare Inc.
• Horiba Ltd.
• Luminex Corporation
• Merck Group
• Perkinelmer Inc.
• Promega Corporation
• Thermo Fisher Scientific Inc.
• Waters Corporation, etc.

Breakup by Analysis Type:

• Structural Proteomics
• Functional Proteomics
• Protein Expression Proteomics

Breakup by Component Type:

• Core Proteomics Services
• Bioinformatics Software and Related Services

Breakup by Technology:

• Spectroscopy
• Chromatography
• Electrophoresis
• Protein Microarrays
• X-Ray Crystallography
• Surface Plasmon Resonance
• Others

Breakup by Application:

• Protein Expression Profiling
• Proteome Mining
• Post-translational Modifications

Breakup by End-User:

• Clinical Diagnostic Laboratories
• Research Organizations (Drug Discovery)
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Competitive Structure
• Profiles of Key Players

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Other Reports of IMARC Group:

• https://www.imarcgroup.com/electric-vehicle-charging-station-market
• https://www.imarcgroup.com/mass-notification-systems-market
• https://www.imarcgroup.com/pharmacogenomics-market
• https://www.imarcgroup.com/virtual-reality-market
• https://www.imarcgroup.com/smart-display-market
• https://www.imarcgroup.com/luxury-travel-market

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.